‘This is what democracy looks like’: Anti-Trump rally marches through Boston
A crowd of more than a thousand marched from Boston Common to the JFK Federal Building in protest of the Trump administration ...
Moderna is counting on its product pipeline to resuscitate its ailing stock
Moderna Inc.’s stock erased early losses to gain 3.4% on Friday, after the biotech company posted a wider-than-expected ...
Boston developer wins his 3rd office conversion approval in a year
A Boston developer won planning-board approval for his third office-to-housing conversion under a city tax-break program.
Moderna Scales Down Manufacturing
The biotech giant reported a bigger-than-expected quarterly loss. Finance chief James Mock attributed the loss to a scale down.
Moderna’s Shot Sales, Canceled Contract Lead to Another Loss
The company’s earnings update initially discouraged investors, who traded the stock down as much as 8.4% when the market opened Friday. The shares later rallied, gaining as much as 6.2%, amid broader ...
‘A force of nature’: How nonprofit founder Connor Schoen, 26, bought a downtown office building
The leader of Breaktime, a homelessness nonprofit, engineered a $6 million deal to purchase a five-story building.